🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

9 results for “Cue” Clear

  1. Chirhostim

    Institut für biomedizinische Analytik NMR-Imaging GmbH

    Pancreatic cancer, Intraductal papillary mucinous intraductal neoplasia

    phase 3 small molecule active

    1 trial

  2. CUE-101

    Cue Biopharma

    Head and Neck Squamous Cell Carcinoma

    phase 2 small molecule active

    1 trial

  3. CUE-101

    Cue Biopharma

    Oropharyngeal Squamous Cell Carcinoma

    phase 2 small molecule active

    1 trial

  4. ZENGAC “500 mg Polvere per soluzione per infusione e per uso orale”, Plenvu, polvere per soluzione orale, SELG ESSE polvere per soluzione orale, Avastin 25 mg/ml concentrate for solution for infusion., Tecentriq 1 200 mg concentrate for solution for infusion, Vancomicina Mylan 500 mg polvere per soluzione per infusione

    Istituto Gentili S.r.l.

    unresectable hepatocellular carcinoma (HCC)

    phase 2 small molecule active

    1 trial

  5. chantix

    BRIGHT MINDS BIOSCIENCES INC.

    Varenicline and the Blunting of Cocaine Cues

    phase 2 small molecule terminated

    1 trial

  6. CUE-101

    Cue Biopharma

    Head and Neck Cancer

    phase 1 small molecule completed

    1 trial

  7. CUE-102

    Cue Biopharma

    Colorectal Cancer

    phase 1 small molecule completed

    1 trial

  8. CUE-102

    Cue Biopharma

    Recurrent Glioblastoma

    phase 1 mab active

    1 trial

  9. Rescue Intravitreal Aflibercept Injection

    Regeneron UK Limited

    Neovascular Polypoidal Choroidal Vasculopathy

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources